Dominique Rongier - Alterola Biotech Insider

ALTA -- USA Stock  

USD 1.25  14.15  91.88%

Independent Member of the Supervisory Board
Mr. Dominique Rongier is an Independent Member of the Supervisory Board of Altarea SCA. He is a Member of the Companys Audit Committee and Chairman of the Remuneration Committee. He graduated from the HEC business school in 1967 and served in succession as Auditor with Arthur Andersen, Chief Financial Officer of the Bremond Pierre Vacances Group, and Chief Financial Officer of the Brossette SA Group . In 1987, he designed and set up a holding structure for the Carrefour Group, and from 1988 to 1990, he was Corporationrationrate Secretary of Belier, a member of the HavasEurocom network, before becoming Chief Financial Officer of the holding company Oros Communication, which holds majority interests in the communications sector, from 1991 to 1993. Since September 1993, Mr. Rongier was an independent consultant with DBLP Associes SARL, of which he is manager and majority shareholder. His main activity is strategic and financial management consultancy. In the interim, he was acting Chief Executive Officer of the DMB B France Group for more than two years. Until March 31, 2009, Mr. Rongier was Chairman of a software publishing company specialising in sports and health. Mr. Rongier also holds other mandates, including Member of the Supervisory Board of SCA Altareit and Director of SA Search Partners.
Age: 70        
909-584-5853  http://www.alterolabiotech.com

Management Efficiency

The company has return on total asset (ROA) of (133.34) % which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Entity Summary

Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech operates under Conglomerates classification in USA and traded on OTC Market. It employs 1 people.Alterola Biotech (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.

Alterola Biotech Leadership Team

Stock Performance Indicators

Current Sentiment - ALTA

Alterola Biotech Investor Sentiment
Macroaxis portfolio users are unresponsive in their sentiment towards investing in Alterola Biotech. What is your sentiment towards investing in Alterola Biotech? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Alterola Biotech and U S Bancorp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.